J

John Crown

St. Vincent's University Hospital

ORCID: 0000-0002-3125-7613

Publishes on HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies. 868 papers and 38.4k citations.

PubIndex Score98Top 2%How it's scored

868Publications

38.4kTotal Citations

First publication: 1988First senior author: 1987

HER2/EGFR in Cancer Research Cancer Treatment and Pharmacology Breast Cancer Treatment Studies Advanced Breast Cancer Therapies Monoclonal and Polyclonal Antibodies Research

Top publicationsby citations

MYC as a target for cancer treatment

Michael J. Duffy, John Crown|Cancer Treatment Reviews|2021

Cited by 528

Effects of HER Family–targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer

Denis M. Collins, John Crown|Clinical Cancer Research|2020

Cited by 75

Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma

Omid Hamid, Giuseppe Gullo, Kevin B. Kim et al.|Journal of Clinical Oncology|2024

Cited by 37

Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma

Thamir Mahgoub, John Crown|International Journal of Oncology|2015

Cited by 20

Chromosome centromere copy number amplification associated with exceptional response in HER2-positive metastatic breast cancer patients

Charlotte Andrieu, John Crown|Oncogene|2025

Cited by 1